SBIR/STTR Reauthorization: Navigating the Changes
The SBIR/STTR landscape is shifting, and these changes directly impact how startups secure non-dilutive funding. Dr. Nao Gamo led a focused online session breaking down the latest reauthorization updates, from new disclosure and compliance requirements to rising expectations around commercialization.
This session explained what has changed, how it impacts your application strategy, and what founders must do to stay competitive.
Watch now if SBIR/STTR funding is part of your roadmap, to help you navigate the new terrain with confidence.
Archived Panel Discussions
AI in MedTech
Navigating the FDA Maze
De-Risking MedTech Product Development: From Idea to FDA
Product Market Fit: Align Your Product, Strategy, and Commercialization
IP strategies for Protecting MedTech Innovations in the Digital Age
IP strategies for Protecting MedTech Innovations in the Digital Age
Navigating Clinical Trials: Critical Strategies for MedTech Success
Non-Dilutive Funding for MedTech Innovators - SBIRs and Beyond
From Pitch to Investment: MedTech Fundraising Strategies That Work
Amplify MedTech’s webinar gave us practical insights on reimbursement and payer engagement—truly impactful for our MedTech journey.
DataPorium
★★★★★
Contact
amplifymedtech@gmail.com+1 410-929-5069
© 2026. All rights reserved.
Fueling innovation through community and connection
